Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -1.53% | +14.89% | +92.60% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.60% | 12.5M | |
-1.73% | 105B | |
+3.55% | 97.5B | |
+1.86% | 22.19B | |
-16.50% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.71% | 14.52B | |
+5.03% | 14.09B | |
+24.21% | 10.99B |
- Stock Market
- Equities
- IMNN Stock
- News Imunon, Inc.
- HC Wainwright Starts Celsion at Buy With $16 Price Target